Evidence map›Paper›PMID 20175192›Full record

ReviewDevelopmental dynamics : an official publication of the American Association of Anatomists2010

Cancer models in Caenorhabditis elegans.

Natalia V Kirienko, Kumaran Mani, David S Fay

Abstract readReview
In one paragraph

Review in Developmental dynamics : an official publication of the American Association of Anatomists, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed.

  1. Harnessing coumarin-thio(seleno)cyanate conjugates: potentJournal of enzyme inhibition and medicinal chemistry · 2025
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Biology · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Potent anticancer activity of a novel iridium metallodrug via oncosis.Cellular and molecular life sciences : CMLS · 2022
    Article
  14. Subcritical Water Extraction ofMolecules (Basel, Switzerland) · 2021
    Article
  15. Review
  16. Article
  17. Phenotypic Screening inPharmaceuticals (Basel, Switzerland) · 2020
    Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Natalia V KirienkoUniversity of Wyoming, College of Agriculture, Department of Molecular Biology, Laramie, Wyoming 82071, USA.
Kumaran Mani
David S Fay

Funding

Wyoming IDeA Networks of Biomedical Research ExcellenceP20RR016474 · NCRR · UNIVERSITY OF WYOMING · PI LIBERLES, DAVID A. · 2001 to 2011
$28.2M
Developmental Functions of Rb family proteinsR01GM066868 · NIGMS · UNIVERSITY OF WYOMING · PI FAY, DAVID S · 2004 to 2019
$4.1M
NCRR NIH HHS P20 RR016474NCRR NIH HHS P20RR016474NIGMS NIH HHS GM066868NIGMS NIH HHS R01 GM066868
6 · The paper itself

Abstract

Although now dogma, the idea that nonvertebrate organisms such as yeast, worms, and flies could inform, and in some cases even revolutionize, our understanding of oncogenesis in humans was not immediately obvious. Aided by the conservative nature of evolution and the persistence of a cohort of devoted researchers, the role of model organisms as a key tool in solving the cancer problem has, however, become widely accepted. In this review, we focus on the nematode Caenorhabditis elegans and its diverse and sometimes surprising contributions to our understanding of the tumorigenic process. Specifically, we discuss findings in the worm that address a well-defined set of processes known to be deregulated in cancer cells including cell cycle progression, growth factor signaling, terminal differentiation, apoptosis, the maintenance of genome stability, and developmental mechanisms relevant to invasion and metastasis.

Indexed as

AnimalsCaenorhabditis elegansCell Physiological PhenomenaDisease Models, AnimalNeoplasm InvasivenessNeoplasms

Identifiers

PMID20175192
PMCPMC4098942

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.